All the latest news on the marijuana space delivered directly to your inbox.
TheSeedInvestor
Read our Investor Dashboard on OTC:ABCCF TSX.v ABCN
There will be a sudden wave of "Marijuana Millionaires" in 2017 - will you be one?

 
13x13x1 READ MORE
How To Invest in the Emerging Marijuana Market.
 
LEARN MORE
600x300
Canadian Licensed Producers Prepare for Recreational Cannabis Legalization, Expect Significant Growth in Demand

ABcann Global Corp. (OTCQB: ABCCF) (TSX.V: ABCN) and others prepare for legalized recreational cannabis on July 1, 2018, as expectations see significant growth in demand.

13x13x1 READ MORE
600x300
INMED PHARMACEUTIC COM NPV (OTCMKTS:IMLFF) Is Running: Here’s Why

Insider Financial looks at the recent market run by InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF)

13x13x1 READ MORE
600x300
Canopy Growth Corporation Reports Second Quarter Fiscal 2018 Financial Results as it Expands Infrastructure for Canadian and International Markets

Canopy reports second quarter loss, but revenue increases.

13x13x1 READ MORE
600x300
MedReleaf Corp. Announces $100.5 Million Bought Deal Financing

MedReleaf Corp. Announces $100.5 Million Bought Deal Financing

13x13x1 READ MORE
Please see full disclaimers on the TheSeedInvestor.com website applicable to all content provided by TSI, wherever published or re-published: http://theseedinvestor.com/about/disclaimerDisclaimer.

This news release/advertorial is a commercial advertisement and is for general information purposes only. We are engaged in the business of marketing and advertising companies for monetary compensation. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. It is possible that a viewer’s entire investment may be lost or impaired due to the speculative nature of the companies profiled. Remember, never invest in any security of a company profiled or discussed on this website unless you can afford to lose your entire investment. Also, investing in small-cap and micro-cap securities is highly speculative and carries an extremely high degree of risk. This website makes no recommendation that the securities of the companies profiled or discussed on this website should be purchased, sold or held by viewers that learn of the profiled companies through our website. Compensation: A thirty-six-thousand-dollar investor relations budget is being managed by The Seed Investor. Any funds leftover after expenses for research, overhead, advertising and public relations related to InMed Pharmaceuticals Inc. (ticker symbol (CSE: IN; OTCQB: IMLFF) will be considered profit. The Seed Investor and/or entities related to The Seed Investor hold shares in (CSE: IN; OTCQB: IMLFF) and intend to sell those shares. Please review all investment decisions with a licensed inv­estment advisor. 

 
32x32x1   32x32x2   32x32x3
TheSeedInvestor.com
9375 E Shea Blvd Ste 100
Scottsdale 85260
info@theseedinvestor.com
 
©2018, All Rights Reserved  |  Unsubscribe   |   View this in Browser

To keep receiving emails from us, please add us to your address book.